Key facts
- It has raised $110K; the latest was Seed Round in May 2025.
- Notable investors include Enterprise Ireland, NDRC, Dogpatch Labs, Fidelity Center for Applied Technology, New Frontiers Ireland.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for GClinics
- ·The full record, as it builds
Funding rounds
No funding rounds for GClinics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GClinics
Provider of AI-driven genomics tools intended for precision healthcare. The company's tools integrate genomics with AI to deliver actionable insights, supported by a team of developers and data scientists, enabling healthcare providers to enhance patient care, advance precision medicine and support transformative health outcomes through personalized, data-driven decision-making processes.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2024
- Website
- gclinics.com/
- Ownership
- Privately Held (backing)
GClinics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GClinics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GClinics in its N-PORT filings yet. We sweep new filings monthly.